BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11264031)

  • 1. Candida dubliniensis at a cancer center.
    Sebti A; Kiehn TE; Perlin D; Chaturvedi V; Wong M; Doney A; Park S; Sepkowitz KA
    Clin Infect Dis; 2001 Apr; 32(7):1034-8. PubMed ID: 11264031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida dubliniensis, a new fungal pathogen.
    Gutiérrez J; Morales P; González MA; Quindós G
    J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and molecular characterization of Candida dubliniensis isolates from clinical specimens in Kuwait.
    Ahmad S; Mokaddas E; Al-Sweih N; Khan ZU
    Med Princ Pract; 2005; 14 Suppl 1():77-83. PubMed ID: 16103717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
    Fotedar R; Al Hedaithy SS
    Mycoses; 2004 Apr; 47(3-4):150-5. PubMed ID: 15078432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of Candida dubliniensis strains using heat tolerance tests, morphological characteristics and molecular methods].
    Arikan S; Darka O; Hasçelik G; Günalp A
    Mikrobiyol Bul; 2003 Jan; 37(1):49-57. PubMed ID: 12838678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.
    Luque AG; Biasoli MS; Tosello ME; Binolfi A; Lupo S; Magaró HM
    Mycoses; 2009 Jan; 52(1):53-9. PubMed ID: 18498298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.
    Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF
    Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002.
    Foongladda S; Sakulmaiwatana P; Petlum P; Vanprapar N
    J Med Assoc Thai; 2004 Jan; 87(1):92-9. PubMed ID: 14971541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Candida dubliniensis studies and isolation of Candida types in oropharyngeal specimens from oncologic patients].
    Tekeli A; Dolapçi I; Cesur S; Tekeli E; Içli F
    Mikrobiyol Bul; 2002 Jan; 36(1):57-63. PubMed ID: 12476767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida dubliniensis at a university hospital in Saudi Arabia.
    Fotedar R; Al-Hedaithy SS
    J Clin Microbiol; 2003 May; 41(5):1907-11. PubMed ID: 12734225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
    Jewtuchowicz VM; Mujica MT; Brusca MI; Sordelli N; Malzone MC; Pola SJ; Iovannitti CA; Rosa AC
    Oral Microbiol Immunol; 2008 Dec; 23(6):505-9. PubMed ID: 18954358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
    Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
    Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Candida dubliniensis in a diagnostic microbiology laboratory.
    Momani OM; Qaddoomi A
    East Mediterr Health J; 2005 May; 11(3):366-71. PubMed ID: 16602455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.
    Fleischhacker M; Pasligh J; Moran G; Ruhnke M
    J Clin Microbiol; 2010 May; 48(5):1643-50. PubMed ID: 20200288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study.
    Mokaddas E; Khan ZU; Ahmad S
    Mycoses; 2011 Jul; 54(4):e29-34. PubMed ID: 20002881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.
    Tekeli A; Koyuncu E; Dolapci I; Guven GS; Sahin GO; Uzun O
    Mycoses; 2005 May; 48(3):197-201. PubMed ID: 15842337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular identification of Candida albicans and Candida dubliniensis strains isolated from clinical samples].
    Toraman ZA; Bulut Y; Yilmaz M; Ozdarendeli A
    Mikrobiyol Bul; 2005 Apr; 39(2):199-204. PubMed ID: 16128031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.